Modifies provisions relating to limits on selling or purchasing certain drugs

HB 1201 sets daily, monthly, and annual purchase limits for drugs containing ephedrine, phenylpropanolamine, or pseudoephedrine (common methamphetamine precursors). It restricts sales to no more than 3.6 grams within 24 hours, 7.2 grams within 30 days, and 61.2 grams within a year per individual, requiring all such products to be sold behind pharmacy counters. Pharmacies must track sales and report to the state, while manufacturers must pay fees for a new electronic tracking system starting in 2025. The bill preempts local laws requiring prescriptions for these products and voids existing local ordinances that imposed similar requirements. It directly affects pharmacies, consumers purchasing these drugs, and manufacturers of precursor products.